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ABSTRACT 1 
 2 
To initiate infection, herpesviruses must navigate to and transport their genomes 3 
across the nuclear pore.  VP1-2 is a large structural protein of the virion, conserved 4 
in all herpesviridae and plays multiple essential roles in virus replication including in 5 
early entry.  VP1-2 contains an N-terminal basic motif which functions as an efficient 6 
nuclear localisation signal (NLS). Here we construct a mutant HSV strain, K.VP1-7 
2ΔNLS, which contains a short 7 residue deletion of the core NLS at position 475. 8 
This mutant fails to spread in normal cells, but can be propagated in complementing 9 
cell lines. Electron microscopy (EM) analysis of infection in non-complementing cells 10 
demonstrated capsid assembly, cytoplasmic envelopment and the formation of 11 
extracellular enveloped virions. Furthermore extracellular virions isolated from non-12 
complementing cells had similar profiles and abundance of structural proteins. 13 
Virions containing VP1-2ΔNLS were able to enter and be transported within cells. 14 
However further progress of infection was prevented, with at least a 500-1000 fold 15 
reduction in the efficiency of initiating gene expression compared to the revertant. 16 
Ultrastructural and immunofluorescence analysis reveal that the K.VP1-2ΔNLS 17 
mutant was blocked at the microtubule organising centre or immediately upstream of 18 
nuclear pore docking and prior to gene expression. These results indicate that the 19 
VP1-2 NLS is not required for the known assembly functions of the protein but is a 20 
key requirement for early routing to the nuclear pore necessary for successful 21 
infection. Given its conservation we propose this motif may also be critical for entry 22 
of other classes of herpesviruses. 23 
 24 
 25 
 26 
INTRODUCTION 27 
 28 
The nuclear pore is the conduit for transport between the cytoplasm and nucleus and 29 
as such represents an obligatory pathway that must be navigated very early after 30 
infection by many classes of human viruses (9, 20, 21, 27, 36, 44, 50, 60, 62).  For 31 
herpesviruses, capsid-tegument assemblies must be transported across the 32 
cytoplasm, targeted to and interact with pores, and undergo structural 33 
rearrangements promoting genome exit and transport across the pore where virus 34 
immediate-early gene transcription ensues (14).  A prime candidate within the virus 35 
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encoded proteins for a possible role at this stage of infection is the large tegument 1 
protein VP1-2, the product of the UL36 gene in herpes simplex virus (HSV).  This 2 
protein is conserved across the herpesvirus family and essential for virus replication 3 
(13, 15, 31, 34, 38).  It is a complex, multifunctional protein playing crucial and 4 
distinct roles at various points in the virus life cycle including entry,  capsid transport 5 
and  virion assembly (7, 13, 15, 31, 34, 38, 52, 55). Consistent with a role at the 6 
earliest stages of infection, VP1-2 is among a subset of components classed as 7 
inner tegument proteins based on tight association with capsids during biochemical 8 
extraction and in vivo during entry by immunoelectron and confocal microscopy (19, 9 
30, 37, 40, 45, 51, 61).   Evidence for a key role for VP1-2 early after infection 10 
originated from studies of the temperature sensitive mutant virus tsB7 where at the 11 
restrictive temperature, full capsids accumulated at the nuclear pore and virus gene 12 
expression was profoundly blocked (5, 31).  The defect in tsB7 was mapped 13 
specifically to a single amino acid at residue 1453 in VP1-2 (1).  Supporting evidence 14 
for a role in nuclear entry was obtained from studies of a full deletion mutant of the 15 
UL36 gene (52).  While this mutant does not assemble virions, the authors examined 16 
a potential role for VP1-2 by chemically fusing initially infected cells with surrounding 17 
cells and measuring infection in these secondary nuclei. The UL36 deletion mutant 18 
was completely unable to infect such nuclei in the fused polykaryocytes while in 19 
parallel, a UL36+ve but UL37-ve virus was able to promote infection.   20 
However as indicated above, VP1-2 also clearly plays a pivotal role later in 21 
infection in virion assembly. Thus an additional late defect was identified in strains 22 
carrying the ts VP1-2, resulting in defective cytoplasmic envelopment and a failure to 23 
produce infectious virus (1, 3, 4).   Furthermore, analysis of VP1-2 deletion mutants 24 
have shown that while C-capsids assemble relatively normally in the nucleus, 25 
cytoplasmic envelopment and production of infectious virus is completely blocked 26 
(13, 15, 52), indicating a critical role in assembly after capsid formation. Current work 27 
indicates that, consistent with its definition as an inner tegument protein, that VP1-2 28 
is among the first proteins, if not the first, to be recruited onto assembled capsids 29 
and is essential for the further recruitment of additional tegument proteins and 30 
subsequent envelopment (15, 30, 32, 52).   VP1-2 has also been reported to have 31 
additional functions, including capsid motility on microtubules, a role that could also 32 
be connected to assembly (37, 38, 51, 55, 61).  The protein also encompasses a 33 
unique class of ubiquitin specific protease embedded within its extreme N-terminus 34 
 4
(28, 54) which while potentially dispensable for core functions of virus assembly in 1 
tissue culture, may play a role in aspects of replication in vivo (24, 35). 2 
However, the essential nature, the multiplicity of roles and the very large size 3 
of VP1-2 has made difficult the mechanistic dissection of pathways in which it is 4 
involved.  In particular considering the dual roles in assembly and in entry, deletion 5 
of the protein results in failure to assemble virions and prevents further analysis of its 6 
role in entry.  Progress in characterisation of specific determinants and a mechanistic 7 
framework with which to understand the detailed mechanisms involved requires 8 
identification of variants which support virion assembly but remain defective for 9 
replication. Such variants represent candidates for a role in virus entry.  As part of 10 
our aim to understand both herpesvirus early entry mechanisms and the multiplicity 11 
of role(s) of VP1-2, we previously demonstrated that VP1-2 contains an efficient 12 
nuclear localization signal (NLS) adjacent to the N-terminal ubiquitin hydrolase 13 
domain. A similar motif in the PRV VP1-2 homologue has also been shown to be 14 
functional in nuclear localisation (43). Here we construct and analyse a HSV mutant 15 
containing a short deletion of this NLS. Our data indicate that the short NLS at 16 
position 475 in VP1-2, which exhibits strong positional and sequence conservation in 17 
the homologues in all herpesviruses (2),  is essential for virus spread and further that 18 
while dispensable for virion assembly per se, it is key to normal entry early in 19 
infection via routing to the nuclear pore. 20 
 21 
 22 
MATERIALS AND METHODS 23 
 24 
Cells, virus, infections and transfection.  25 
Vero and HS30 cells, a derivative of Vero cells containing the UL36 gene (13), were 26 
grown in Dulbecco’s modified minimal essential medium (DMEM, Gibco) containing 27 
10% newborn calf serum (NCS) and penicillin/streptomycin.  RSC (rabbit skin cells) 28 
and RSC-HAUL36 cells, a derivative of RSC cells containing the UL36 gene (52) 29 
were grown in DMEM containing 10% foetal calf serum (FCS) supplemented with 30 
non-essential amino acids. HS30 and RSC-HAUL36 were propagated in 0.5 and 10 31 
mg/ml respectively of geneticin. For some experiments we used HaCaT cells (human 32 
keratinocytes) grown in DMEM containing 10% FCS.  Not only do these cells 33 
represent a relevant cell type for HSV replication, but from comparative analysis we 34 
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obtained a several fold increase in extracellular virus yields of any strain analysed, 1 
and therefore used these to produce w/t and mutant viruses. Routine 2 
characterisation of virus infection was performed exactly as described previously (6). 3 
 4 
Construction of a virus mutant expressing VP1-2ΔNLS.  5 
A mutant virus expressing  VP1-2 lacking the core NLS was constructed in the 6 
background of HSV-1 strain KOS previously cloned in a bacterial artificial 7 
chromosome (16). The BACmid was grown in E. coli strain GS1783. The strategy 8 
involved recombinational insertion of a cassette for kanamycin resistance adjacent to 9 
the mutated sequence, selection for kanamycin resistance, followed by 10 
recombination excision and counter selection was carried out exactly as described 11 
previously (6). PCR was carried out with the primers below using pEPKan-S (57) as 12 
a template. Template DNA was digested by incubating the PCR reaction mix with 20 13 
U DpnI for 1 h at 37°C and the PCR product was purified using a QIAQuick Gel 14 
extraction kit (Qiagen) after separation on a 0.8% agarose gel.  15 
COL414: Forward primer for UL36 NLS deletion 16 
CGTCCCGGTTGGTCGGCACCGGGCACGCTACTCGGCCGGCACCTGGACTCCG17 
CCTTC CAGAGGATGACGACGATAAGTAGGG 18 
COL417: Reverse primer for UL36 NLS deletion 19 
CCGAAGTCAGGTCTTCGACGCTGGAAGGCGGAGTCCAGGTGCCGGCCGAGTA20 
GCGTG CCCCAACCAATTAACCAATTCTGATTAG 21 
The PCR product (100 ng) was electroporated and bacteria selected for resistance 22 
to chloramphenicol and kanamycin. Resistant colonies were screened by restriction 23 
digest. Appropriate colonies were grown and I-SceI induced and the culture heat-24 
shocked at 42°C for 30 min. Candidate colonies that had lost the kanamycin 25 
resistance gene were identified by replica plating and BAC DNA isolated and 26 
examined by restriction digestion. BAC DNA (100 μg) together with 1 μg pGS403 27 
encoding Cre recombinase, was then transfected into HS30 cells to reconstitute 28 
HSV-1 and excise the BAC backbone from the viral genome.  Plaques were isolated 29 
and multiply plaque-purified in complementing RSC-HAUL36 cells. These cells were 30 
used for subsequent routine propagation since spontaneous revertants were not 31 
produced while in complementing HS30 cells, revertants were observed, (though still 32 
with a low frequency). The mutant virus was designated K.VP1-2ΔNLS. The 33 
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presence of the deletion covering 7 residues of the VP1-2 NLS substitution was 1 
confirmed by sequencing the first 1353 nucleotides from purified DNA stocks of 2 
mutant or parental virus isolates. No other mutations were observed in this region 3 
and this fragment was sufficient to rescue K.VP1-2ΔNLS by cotransfection with viral 4 
DNA and recombination. A revertant of K.VP1-2ΔNLS was generated by co-5 
transfecting DNA from the K.VP1-2ΔNLS mutant virus together with the w/t UL36 6 
gene, followed by growth and plaque purification on non-complementing RSC cells.  7 
The revertant virus was designated K.VP1-2ΔNLS.R. Restoration of the deleted 8 
residues was confirmed by sequencing DNA from the isolated revertant virus.  For 9 
purification of extracellular virions by gradient centrifugation, RSC-HAUL36 cells 10 
were infected with K.VP1-2ΔNLS or the revertant at a moi of 0.001 and the medium 11 
collected after complete cpe, clarified by centrifugation (2000 rpm 10 min) and virus 12 
pelleted from the supernatant by centrifugation at 19k for 90 min.  The pellet was 13 
then resuspended in PBS (overnight at 40C) and loaded onto 5-15% Ficoll gradients 14 
made in PBS and samples centrifuged at 25k rpm for 2 h. The lower band containing 15 
enveloped virions was extracted by needle puncture, concentrated (25k rpm for 60 16 
min) and the pellet then resuspended in PBS and frozen.     17 
 18 
Purification of viral DNA from K.VP1-2ΔNLS.  19 
For purification of viral DNA, RSC-HAUL36 cells (10 x 175 cm2 flasks) were infected 20 
(moi 0.001) and virus isolated from the medium after advanced cpe was observed. 21 
The media was first clarified by centrifugation (2k rpm for 20 min) and virus pelleted 22 
from the supernatant (19k rpm for 90 min). The pelleted virus was resuspended 23 
gently in 5 ml of buffer (10 mM Tris-Hcl [pH 7.6], 1 mM EDTA, 1% SDS), containing 24 
50 μg/ml proteinase K and incubated at 50°C for 4 h and DNA extracted by 25 
successive rounds of phenol and phenol/chloroform extraction. The final aqueous 26 
phase was precipitated by addition of 0.1 volumes 3M sodium acetate [pH5.3] and 2 27 
volumes of EtOH, gentle mixing and incubation at -200C for 30 min. Finally, the DNA 28 
was pelleted  (3500 rpm for 30 min ) at 4°C and washed with 70% EtOH and air 29 
dried, then resuspended in 100-200 μl of H20. The DNA was stored at -80°C. 30 
 31 
 32 
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Immunofluorescence studies.  1 
Immunofluorescence analysis was performed exactly as described previously (3) 2 
using the following antibodies: ICP4 (Virusys, 1:400); ICP8 (a kind gift from Roger 3 
Everett, 1:2000), pUL37 (a kind gift from Prashant Desai, 1:800); VP16 (LP1 4 
antibody, a  kind gift from Tony Minson, 1:400); VP5 (East Coast Bio, 1:500); 5 
polyclonal VP1-2, (αVP1-2NT1r, 1:250) (3); monoclonal VP1-2 (CB4, 1:2) and anti 6 
PCM1, (Santa Cruz Technologies, 1:50). PCM1 was used for detection of the region 7 
around the microtubule organising centre since it gave better staining under 8 
conditions for capsid detection than other markers tested, such as γ-tubulin. Samples 9 
were collected at times indicated, washed with PBS, fixed with methanol (5 min at -10 
200C) and blocked with PBSB (PBS containing 10% NCS), supplemented for αVP1-11 
2NT1r with 0.5 mg/ml human IgG (Sigma) for 1 h at room temperature. After 12 
processing images were collected using Zeiss x10, x40 LD  or x100 (Plan-13 
Apochromat, 1.4 numerical aperture) lenses. Images for each channel were captured 14 
sequentially with a Retiga 2000R camera using Image Pro plus software. Composite 15 
illustrations were prepared using Adobe software. Example images shown are 16 
representative of numerous images gathered for each virus and condition.  For 17 
studies of the presence and subcellular distribution of HSV virions, infections were 18 
performed at a moi of 100. The cells were pre-chilled at 40C prior to infection. The 19 
monolayers were washed once with cold media and the inoculum added for further 20 
incubation at 40C for 1 h.  The inoculum was then removed, pre-warmed media 21 
containing 2% NCS was added and the cells incubated for different lengths of time at 22 
370C.  The samples were then washed three times with cold PBS and fixed 3.7% 23 
PFA in PBS for 20 min at room temperature, and permeabilised with 0.1% TritonX-24 
100 prior the incubation with anti-VP5, pUL37, VP1-2 (CB4) or anti-PCM1 antibody. 25 
Controls included parallel analysis of infected cells incubated at 40C without shifting 26 
to 370C. Images for capsid localisation were collected with a Zeiss LSM510 confocal 27 
microscope x40 or x63 Plan-Apochromat, 1.4 numerical aperture lenses. For studies 28 
of viral entry, so as not to be selective, images were collected throughout the cell in 29 
multiple Z-stacks, compiled and the total images shown. To demonstrate the capsid 30 
congregation around the microtubule organising centre (MTOC) e.g., Figure 7, single 31 
confocal slices were taken using a pinhole size of 2.  Channels were captured 32 
sequentially using Axiovision acquisition software  and composite illustrations 33 
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prepared using Adobe software.  For quantitation of capsid localisation, a region of 1 
interest (ROI) comprising a 2 µm diameter circle centred around the MTOC 2 
(identified by PCM1 staining) was defined for each cell in a field. In an unbiased way, 3 
i.e. including all cells with definable MTOCs, these ROIs were then applied to the 4 
green channel capsid (VP5 localisation), and the pixel intensity calculated for every 5 
ROI after background subtraction.  This analysis was performed for approximately 6 
100 cells in several independent fields for the mutant or revertant virus. The results 7 
were plotted as the pixel intensity within each MTOC-associated ROI for each cell, 8 
for each virus. 9 
 10 
Electron microscopy studies.   11 
For analysis of assembly (Figure 5) RSC or Vero cells were infected with KOS w/t or 12 
K.VP1-2ΔNLS at a moi of 5 and processed 16 h after infection. For early entry 13 
studies (Figure 8,9) cells were infected at a moi of 500. Cells were washed with ice-14 
cold PBS and fixed for 30 min at room temperature in 0.5% glutaraldehyde  in 200 15 
mM sodium cacodylate buffer, washed in buffer and processed into Epon and 16 
sectioned. Samples were viewed by using an FEI Tecnai G2 electron microscope 17 
(FEI, Eindhoven, The Netherlands) with a Soft Imaging System Megaview III charge-18 
coupled device camera. Images were collected at 1,376 × 1,032 × 16 pixels by using 19 
analysis version Docu software (Olympus Soft Imaging Solutions, Münster, 20 
Germany).  For staining of virus particles, suspensions of extracellular pelleted virus 21 
were absorbed onto 400 mesh formvar carbon coated glow discharged grids and 22 
negatively stained with 1% uranyl acetate. 23 
 24 
SDS-PAGE and Western blotting.   25 
Mock or infected cell monolayers were harvested in standard SDS sample buffer. 26 
Samples were lysed either using a sonicator waterbath or by needle shearing using 27 
a 25G needle and boiled for 5 min prior to electrophoresis. Equal cell samples were 28 
analysed on  3-8 % gradient Tris-acetate gels or  10% Tris-glycine gels and 29 
transferred to nitrocellulose membranes. Membranes were blocked in PBS 30 
containing 0.5x blocking solution (Licor Biosciences). Primary and secondary 31 
antibodies for immunodetection were diluted in PBST (PBS plus 0.1% Tween 20 32 
containing 5 % dried milk). Target proteins were visualized using DyLight-conjugated 33 
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secondary antibodies (Pierce 1/10000) and developed using Li-Cor Bioscience 1 
Odyssey Infrared Imaging System. Odyssey v3.0 software was used for 2 
quantification with linearity of measurement being confirmed using a standardisation 3 
bioassay with serial dilutions of sample inputs.  Values of specific viral protein 4 
intensities were normalized against actin values. Primary antibodies included anti-5 
ICP4 (Virusys, 1/1000); anti-ICP8 (1/2000); anti-VP5 (East Coast Bio, 1/3000), anti-6 
HA (Invitrogen, 1/10,000), anti-pUL37 (a gift of P.Desai, 1/10,000), anti-pUL25 (a gift 7 
of V.Preston, 1/1000), LP1, anti-VP16 (1/4000,  anti-VP1-2 (anti-NT1, 1/2000), anti-8 
gB (1/10,000), anti-gD (a gift of G Cohen,1/10,000), anti-pUL6 (a gift from Arvind 9 
Patel, 1/1000) and monoclonal anti-actin (Sigma, 1/500).  10 
11 
 10
RESULTS 1 
 2 
Growth characteristics of K.VP1-2ΔNLS. 3 
We previously identified a short, highly conserved basic motif in VP1-2, embedded 4 
within an otherwise poorly conserved region at the N-terminus of the protein (Figure 5 
1a). We demonstrated that this motif could function as an efficient nuclear 6 
localisation signal (2). Further complementation assays with a mutant VP1-2 lacking 7 
the NLS indicated that it was important for virus growth.  However definitive 8 
elucidation of its role requires the analysis of a virus lacking the motif.  Therefore we 9 
constructed a mutant HSV KOS strain containing a short deletion of the 7 amino 10 
acids which provided the core NLS function (see materials and methods).  11 
Anticipating that this determinant would be important for virus growth we isolated and 12 
plaque purified the mutant virus on complementing cell lines (either HS30 or RSC-13 
HAUL36) containing the wild-type (w/t) gene for VP1-2. The mutant replicated on the 14 
complementing cells, purified virus stocks were obtained and the deletion confirmed 15 
by sequencing across the UL36 gene. This virus designated K.VP1-2ΔNLS 16 
replicated only in complementing lines with plaque formation roughly comparable to 17 
the KOS w/t parental virus (Figure 1b,c).  In striking contrast, in parallel assays in 18 
non-complementing Vero cells absolutely no plaque formation was observed and 19 
plaquing efficiency was decreased by at least 7 orders of magnitude compared to 20 
that on complementing cells (Figure 1b,c).   Identical results were obtained when 21 
comparing plaque formation in complementing RSC-HAUL36 cells versus RSC cells 22 
(data not shown).   Basically no plaques of any size were observed in Vero cells, 23 
RSC, Hep2 cells or any other cell type tested, though cpe was observed at high 24 
levels of virus inoculum.  We next compared replication in multi-step growth curves 25 
in complementing versus non-complementing lines, assaying yield on 26 
complementing cells. Consistent with the lack of plaque formation, we observed a 27 
virtually complete absence of production of infectious virus (Figure 1d).    28 
We also tested growth after high multiplicity infection in both Vero versus 29 
HS30 cells or RSC versus RSC-HAUL36 cells, with virus yields titred on the 30 
complementing cells. The results were similar in both situations and are shown in 31 
Figure 1e for Vero versus HS30. Growth of the KOS parental virus was 32 
approximately the same in both cell types.  For K.VP1-2ΔNLS, while replication 33 
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kinetics and yields were similar to the parental virus in HS30 cells,  yields in the non-1 
complementing Vero cells were substantially delayed and reduced by an order of 3-4 2 
logs (Figure 1e). Notwithstanding this reduction, it was clear that after the eclipse 3 
phase, infectious virus was produced from non-complementing cells after a high moi 4 
infection, that could infect and form plaques in complementing cells but not in non-5 
complementing cells. Similar results were obtained in comparing RSC versus RSC-6 
HAUL36 cells (data not shown). 7 
To ensure that the profound phenotype of the mutant was due to the NLS 8 
deletion, we rescued K.VP1-2ΔNLS with w/t UL36, isolating the revertant termed 9 
K.VP1-2ΔNLS.R, and confirming restoration of the basic 7 amino acids by 10 
sequencing of purified viral DNA. The revertant could now propagate and plaque on 11 
any non-complementing cell type.  A comparison of growth on non-complementing 12 
RSC cells demonstrating complete restoration of plaque formation is shown in 13 
(Figure S1a,b), with plaquing efficiencies now identical on non-complementing 14 
versus complementing cells. Plaque size for the revertant K.VP1-2ΔNLS.R was also 15 
comparable with that for the parental KOS w/t (Figure S1c). Protein expression, 16 
exemplified by ICP4 and ICP8 were restored in the revertant demonstrating 17 
progressive accumulation after low moi multi-step replication, unlike the virtual 18 
complete block for the mutant (Figure S1d).  Taken together, the observation of 19 
complementation in cells containing UL36 and the reversion of phenotype by 20 
restoration of the basic motif, confirms that this 7 amino acid deletion of the NLS is 21 
the basis of the profound defect in replication and spread.  22 
K.VP1-2ΔNLS,  when amplified on complementing cells (which for ease of 23 
future reference we term K.VP1-2ΔNLSC), clearly entered complementing cells and 24 
spread. We wished therefore to examine whether, although it could not form plaques 25 
at all, K.VP1-2ΔNLSC could enter non-complementing cell types, with the defect in 26 
plaque formation being in some later aspect of propagation.  To examine this we 27 
used serial dilutions in Vero cells similar to those in the plaque assays (Figure 1), but 28 
assaying by immunofluorescence to detect virus protein expression at the cell level. 29 
We observed that after 2-3 days when normal plaque formation for KOS w/t had 30 
spread and contained hundreds of infected cells,  single antigen positive cells were 31 
observed for K.VP1-2ΔNLSC (Figure 2a, arrows) but these cells showed no 32 
progression of infection to surrounding cells.  Identical results showing bright antigen 33 
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positive single cells were obtained for a number of virus proteins, demonstrating 1 
firstly their expression and at the same time, lack of virus spread.  Identical results, 2 
showing initial single infections and no spread, were obtained on a number of 3 
standard cell types including RPE, HFF and HaCaT (data not shown). 4 
Considering the known recruitment of VP1-2 to virions, the reasonable 5 
interpretation of these results is that when K.VP1-2ΔNLSC is propagated in 6 
complementing cells, the w/t VP1-2 from the cell line is recruited into virions which 7 
can then infect non-complementing cells, but in which further progression is 8 
profoundly blocked at one or more stages (see also below).  To confirm the 9 
recruitment of w/t VP1-2, we analysed the expression of the w/t VP1-2 in the 10 
complementing cells, in this case in RSC-HAUL36 cells, during infection with K.VP1-11 
2ΔNLSC.  This is made possible since the w/t VP1-2 in this line contains an HA-12 
epitope tag enabling selective detection (52). The results show that while mock-13 
infected RSC-HAUL36 cells expressed no detectable VP1-2.HA,  infection with 14 
K.VP1-2ΔNLSC induced the endogenous protein resulting in detectable levels from 15 
12 h onwards (Figure 2b).   We further analysed gradient purified extracellular virus 16 
particles of K.VP1-2ΔNLSC (see below), demonstrating the presence of the HA-17 
tagged w/t VP1-2 in the virions (Figure 2b, lane 10,11). These data confirm that, as 18 
expected, complementation is due to the incorporation of the w/t VP1-2 during 19 
propagation of K.VP1-2ΔNLSC.  It is possible that in complementing cells, the mutant 20 
VP1-2 is also recruited to virions in addition to the w/t protein but we cannot 21 
discriminate between the two proteins.  The ΔNLS propagates in complementing 22 
cells while there is no spread at all in non-complementing cells.    In the following 23 
series of experiments we addressed the key questions of whether, in non-24 
complementing cells, particles were assembled and whether they contained the 25 
mutant VP1-2, (which in non-complementing cells could only be mutant VP1-2) and if 26 
these events occur,  what was the nature of the profound block to virus spread.  27 
     28 
Analysis of protein expression in K.VP1-2ΔNLS infected cells. 29 
To that end we first examined various parameters of infection in non-complementing 30 
cells comparing K.VP1-2ΔNLSC with the revertant K.VP1-2ΔNLS.R, during high moi 31 
infection (based upon titres obtained in complementing cells). First examining virus 32 
protein synthesis at 2-4 h intervals for 24 h, we observed virtually normal kinetics 33 
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and accumulation for representative immediate-early, early and late virus proteins, 1 
including in this latter class those proteins which have been shown to interact with 2 
VP1-2 (Figure 3a). No major differences were observed for a number of additional 3 
representative proteins including VP5, pUL37, pUL25 and the glycoprotein gD.   For 4 
VP1-2 itself we noted a modest decrease in levels compared to infection with the 5 
revertant, though this would not be likely of itself to explain the profound phenotype 6 
in replication (see also below).  We noted also in more refined analysis of the early 7 
part of infection, sampling every hour to 12 h, that there appeared to be a slight 8 
delay in accumulation of ICP4, though again this did not appear to have a significant 9 
effect on e.g., accumulation of ICP8 (Figure 3b) or other late proteins as indicated 10 
above.   11 
 12 
Normal localisation of candidate virus proteins. 13 
We also analysed localisation of candidate proteins after infection in non-14 
complementing cells by immunofluorescence.   Typical results obtained at 16 h post 15 
infection are shown in Figure 4.  Generally expression and localisation of proteins 16 
including VP5, VP16, and pUL37 could not be differentiated between K.VP1-2ΔNLSC 17 
and the revertant virus (Figure 4a).  VP5 and VP16 were observed in nuclear 18 
patterns with accumulation in replication compartments with additional cytoplasmic 19 
VP16, as previously reported. pUL37 was also observed in a cytoplasmic pattern 20 
that could not be differentiated between mutant and revertant.  For VP1-2 itself, we 21 
have previously reported on localisation in infected Vero cells showing that although 22 
the protein contains an NLS, the majority was found in the cytoplasm, though with a 23 
discernible minor population in the nucleus (2).  Interestingly in this current work in 24 
RSC cells, we found little evidence for a population of nuclear VP1-2, detecting 25 
mainly a cytoplasmic pattern, frequently in a perinuclear or aggregated pattern, 26 
though the comparatively rapid rounding up of infected RSC cells made localisation 27 
studies more difficult (Figure 4b).  Nevertheless we found little difference in 28 
localisation of VP1-2 comparing infection with the mutant and revertant viruses. To 29 
further examine whether we could detect any difference in VP1-2 we also examined 30 
localisation in infected Vero cells (Figure 4b).  In this case, again while the majority 31 
of the protein was in the cytoplasm frequently in large perinuclear punctae, we could 32 
now detect a population of nuclear VP1-2 as previously reported. Indeed a 33 
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discernible difference was now observed, with K.VP1-2ΔNLS exhibiting little 1 
detectable nuclear VP1-2.   This result serves to illustrate a potential phenotype of 2 
the NLS deletion on de novo synthesised VP1-2, at least where nuclear VP1-2 can 3 
be detected.  However such a difference was not readily discernible in RSC cells 4 
neither in other cell types analysed such as HaCaT (data not shown), where clearly 5 
the w/t virus could replicate normally but without significant levels of nuclear VP1-2.  6 
We do not know the reason for the cell type difference in VP1-2 location but possible 7 
explanations include differences in VP1-2 cleavage or non-specific breakdown in 8 
different cells. A comprehensive analysis of the localisation of all virus encoded 9 
proteins, ultimately aimed at addressing virion formation in K.VP1-2ΔNLS is beyond 10 
the scope of this work and tractability.  However within the limits for these types of 11 
analyses, the results indicate normal expression levels and localisation for a series 12 
of representative proteins.  Moreover such a comprehensive analysis is rendered 13 
unnecessary in the light of additional results below. 14 
 15 
Virion assembly during infection by K.VP1-2ΔNLS.  16 
Based on the results above, the profound defect in K.VP1-2ΔNLSC when infecting 17 
non-complementing cells is clearly at a stage after initial infection.  Considering the 18 
observations of normal protein synthesis, at least of all candidates examined 19 
including late proteins, the next key question was whether capsids and virions would 20 
be assembled at all during infection with the mutant, with the defect being at some 21 
stage downstream of this,  or whether the deletion of the motif in VP1-2 prevented 22 
some late stage of assembly itself.  To address this, we first performed electron 23 
microscopy (EM) analyses of non-complementing cells infected by the mutant in 24 
comparison to the w/t virus. The results (Figure 5) generally indicated little 25 
discernible difference between the mutant and w/t virus. Importantly formation of full 26 
capsids was observed in the nucleus of cells infected with K.VP1-2ΔNLS (Figure 5a, 27 
arrows) and the w/t virus (Figure 5d, arrows).  Cytosolic capsids were also observed 28 
either as free capsids but also in membrane wrapping intermediates, examples of 29 
which are shown (Figure 5b,e, arrows).   Finally, enveloped particles were also 30 
observed at the cell surface for both K.VP1-2ΔNLS and the w/t virus (Figure 5c,f).  31 
Additional examples showing readily detectable cell surface or extracellular 32 
enveloped virions for the K.VP1-2ΔNLS mutant are show in panels g,h.   Over the 33 
 15
course of this work, we could detect no significant difference in capsid or enveloped 1 
particle formation in the nucleus and cytoplasm between the mutant and w/t virus 2 
(see additional data below).  Clearly these data indicate that the profound defect in 3 
ΔNLS propagation is not due to a defect in the known requirement for VP1-2 for 4 
virion assembly per se. They also demonstrate that the deletion did not affect the 5 
global folding and functioning of the protein, since VP1-2 is known to be essential for 6 
assembly and for multiple interactions necessary for this complex activity. Given that 7 
we could now observe virion formation and extracellular virus after infection by 8 
K.VP1-2ΔNLSC in non-complementing (i.e., UL36 –ve) cells, we termed such virions 9 
K.VP1-2ΔNLSNC.   10 
 11 
Extracellular virion formation by K.VP1-2ΔNLS. 12 
From the observations of on the one hand, the profound defect in spread seen after 13 
low multiplicity infection, while on the other hand the very similar levels of protein 14 
expression and the formation of enveloped virions, the implication of our studies was 15 
that K.VP1-2ΔNLSNC extracellular virions were formed but would be blocked at some 16 
stage of subsequent infection in secondary cells. We next performed a more 17 
quantitative analysis of virion production and infectivity.  Since multi-round virion 18 
production was impossible, we performed high moi infections in non-complementing 19 
cells (in this case HaCaT human keratinocytes, which from comparative analysis 20 
generally produced increased yields of all HSV-1 strains).   Cells were infected with 21 
the mutant or revertant virus at a moi of 1 (based in titres in complementing cells) 22 
and the media harvested at 16 h post infection.  The media was clarified and 23 
extracellular virus then pelleted and analysed firstly by SDS gel electrophoresis and 24 
total protein staining.   The results showed similar levels of extracellular virion 25 
production. When normalised for levels of major capsid protein by minor adjustment 26 
little significant difference in qualitative or quantitative terms could be observed 27 
between the virion protein profiles (Figure 6a). In particular there was no difference 28 
in the relative abundance of VP1-2 itself, e.g., compared to major capsid protein 29 
VP5.  Further analysis by western blotting of a number of structural proteins 30 
including VP5, VP1-2, pUL37, VP16, pUL25, gB and pUL6 also showed little 31 
difference between the mutant and revertant particles (Figure 6b).    Without a 32 
complete comprehensive analysis of all virus (and host) proteins, and their potential 33 
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modifications, it is formally impossible to state that there were no qualitative 1 
differences in the protein profiles of the mutant and revertant particles (with the 2 
implication that the deletion of NLS of VP1-2 was responsible for any proposed 3 
differences).  However within the limitations of SDS-PAGE and Western blot analysis 4 
of extracellular particles, we could not detect significant differences between the 5 
mutant and revertant protein profiles of extracellular virions.  We further analysed 6 
these extracellular particles by negative staining observing at least as many particles 7 
from the K.VP1-2ΔNLS infected medium. While inherent in such analysis, stain 8 
penetration is not homogeneous and a range of particles are observed, no significant 9 
differences were detected between the mutant and revertant.  Sample images 10 
showing stained particles for the mutant and revertant samples are shown in Figure 11 
6c. Taking altogether with the thin section EM analysis and expression data, these 12 
data demonstrate little defect in virion assembly and release of K.VP1-2ΔNLS.  13 
In contrast, there was a very considerable difference in infectivity.  14 
Normalising for major capsid protein in the extracellular virus preparations, infectious 15 
titres of the mutant virus, (analysed by titration in complementing HS30 cells), was of 16 
the order of 1000-fold lower than the revertant (Figure 6d).   This result is consistent 17 
with the initial analytical scale analysis (Figure 1), where despite a complete block in 18 
spread after single cell infection,  some infectious virus was produced after high moi 19 
infection but at approximately 1000-fold lower efficiency.  The implications of the 20 
current EM and extracellular virus analyses, are that this decrease is not due to a 21 
defect in the production of virus particles, but rather that such particles are produced 22 
and are profoundly reduced in their ability to initiate infection in a new cell.    23 
 24 
Block to infection in K.VP1-2ΔNLSNC. 25 
To characterise the block to infection further we next examined the mutant virus now 26 
made in non-complementing cells, i.e., K.VP1-2ΔNLSNC, in low multiplicity infections 27 
in non-complementing cells, identifying successfully infected cells by 28 
immunofluorescence similar to that shown in Figure 2. The implication of our results 29 
in the previous section would be that with standardised amounts of infecting 30 
particles, the numbers of cells initiating infection would be considerably reduced in 31 
the mutant compared to the w/t virus. We infected Vero or HS30 cells with a series of 32 
dilutions of the extracellular virus preparations, standardised on major capsid protein 33 
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(which we generally found more consistent than particle counts) and designed to 1 
give 1/1000, 1/100 to 1/3 cells infected (based on titres of the revertant virus) and 2 
enumerated antigen positive cells in multiple fields for the revertant and NLS mutant. 3 
Typical fields shown are Vero cells with the highest amount of input virus which 4 
emphasises the difference in infectivity between the revertant and mutant (Figure 5 
6e).  At this input, evaluating 1392 cells in several fields, 398 were positive for ICP4 6 
protein synthesis for the revertant virus.  An approximately 2-fold higher rate of 7 
infection was observed in HS30 cells (Figure 6f).  In striking contrast for the mutant 8 
evaluating 1685 cells no positive cells were detected in Vero cells and of 1442 HS30 9 
cells, 8 were positive for ICP4 (Figure 6f).  10 
  We also examined infection at nominally higher multiplicities and examined 11 
protein synthesis by Western blotting (Figure 6g).   We infected cells with virus 12 
purified from extracellular medium, at an input of 5 pfu/cell (based on titres of the 13 
revertant) or equal input inoculum for the mutant again standardised on VP5 capsid 14 
protein levels. The results demonstrated that while we could readily detect e.g. ICP8 15 
or VP5 protein synthesis for the revertant, we detected little protein synthesis for the 16 
VP1-2.ΔNLS mutant, with only minor amounts of these proteins observed very late 17 
after infection (Figure 6g).  Altogether these data demonstrate a profound block to 18 
infection by K.VP1-2ΔNLSNC particles.  19 
There could be several explanations for the block in K.VP1-2ΔNLSNC infection 20 
including virus entry to the cells or some block in virus gene expression per se.  21 
Such explanations would invoke a critical role of the NLS of VP1-2 in assembly of a 22 
particle that would fuse normally (which while formally possible seemed less likely to 23 
us) or a role of the NLS in immediate early expression per se, which also seemed 24 
less likely.  Given the strong evidence from previous analysis for a role of VP1-2 in 25 
transport to and docking with the nuclear pore (1, 4, 31, 52), it seemed reasonable to 26 
propose that disruption in some aspect of the early intracellular pathway may 27 
underpin the defect in K.VP1-2ΔNLSNC.   28 
To that end we next examined localisation of infecting capsids in cells infected 29 
with K.VP1-2ΔNLSNC or the revertant by immunofluorescence (Figure 7) and by 30 
electron microscopy (Figure 8,9).  We wished to address the questions of whether 31 
K.VP1-2∆NLSNC particles entered cells, and if so where the apparent block to 32 
infection may be.  For these localisation studies, multiple images were collected in 33 
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the Z-dimension and images compiled to give an accurate representation throughout 1 
the cell. Cells were infected as before with extracellular virus, in this case at a moi of 2 
100 for the revertant or with a standardised input of K.VP1-2ΔNLSNC.   After infection 3 
at +40C the cells were washed, warmed to 370C and incubated for 2  or 4 h. At these 4 
times the cultures were fixed, permeabilised and stained with anti-VP5 antibody.  In 5 
parallel control infections, cells were maintained at +40C to prevent virus entry. This 6 
analysis showed a distinct difference in the behaviour of the mutant and revertant 7 
particles.  8 
For the revertant virus, after shifting to 370C particle staining at 2 h was 9 
distinct from that seen at +40C, with numerous cytoplasmic particles reflecting 10 
particle internalisation (Figure 7a, panels I,II).  By 4h virtually all the cells also now 11 
exhibited homogeneous nuclear staining reflecting successful infection, gene 12 
expression and de novo synthesis of VP5 (Figure 7a, panel III,IV), the latter being 13 
absent when analysis was performed in the presence of cycloheximide (data not 14 
shown). Considering that virtually all the cells were successfully infected by the 15 
revertant and synthesising VP5 (Figure 7a, panel IV), it was surprising that we could 16 
not see abundant nucleocapsid aggregation around the nuclear rim, though 17 
individual particle association could be observed.  Nevertheless a clear difference 18 
was observed with the ΔNLS mutant, though not what we had originally anticipated.  19 
For the mutant virus, the pattern was clearly different at 370C compared to +40C, 20 
reflecting capsid internalisation (Figure 7a, panels V,VI).  However by 2 h the pattern 21 
for the mutant could now be distinguished from the revertant and this became even 22 
more pronounced at 4 h. Thus the ΔNLS mutant was seen congregating in distinct 23 
accumulations in a single perinuclear region, and though capsids were clearly 24 
internalised (see also EM analysis below), none of the cells exhibited the diffuse 25 
nuclear VP5 indicative of de novo synthesis. This pronounced difference in 26 
behaviour between the revertant and mutant virus is clear in panels IV versus VIII 27 
which omits the nuclear counterstain.  The perinuclear accumulation of the mutant 28 
was observed in many cells (Figure 7, panel VIII, indicated by arrows) and was 29 
reminiscent of congregation around the microtubule organising centre (MTOC).  That 30 
the distinct localisation of the ΔNLS capsids represented congregation around the 31 
MTOC is confirmed in Figure 7b (panel I, see also Figure S2) showing a confocal 32 
section, this time co-stained with anti-PCM1, one of a class of centriolar specific 33 
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proteins which associates with cytoplasmic granules and concentrates around the 1 
MTOC and centriolar matrix (12). The extent of congregation was quantified for 2 
revertant and mutant capsids. Defined and unbiased areas of interest (2 µm 3 
diameter circles) were applied around PCM1 foci, and the accumulated density of 4 
pixels in the green VP5 channel in the same areas then calculated.  We evaluated 5 
multiple fields and approximately 130 cells for each virus (Figure 7c, each vertical 6 
bar represents a cell). While a congregation pattern could be observed in some cells 7 
for the revertant virus, the distinction in behaviour in MTOC association between the 8 
two viruses was very clear.  We found that a pixel density of approximately 2000 by 9 
quantitative analysis corresponded to the classification as a cluster by visual 10 
inspection. Using this value as a threshold to aid comparison, approximately 10% of 11 
the cells showed MTOC clustering for the revertant as compared to 75% for the 12 
mutant, though this represents a conservative estimate of the difference in behaviour 13 
which was highly significant (p<0.0001).  14 
The simplest explanation for our results is that the block in VP1-2ΔNLS capsid 15 
transport to the nucleus could be due to a requirement for the VP1-2 NLS for capsid 16 
interactions with cellular machinery.  However, formally it could be that the 17 
requirement for the NLS reflected its involvement in retaining VP1-2 on the capsid 18 
during entry, in order for it to carry out some other function. Considering that the NLS 19 
was not required for VP1-2 recruitment and virus assembly this seems less likely in 20 
our view.  However such a scenario has been proposed for a C-terminal determinant 21 
of VP1-2 (53). We therefore examined VP1-2 presence during infection by K.VP1-22 
2ΔNLS in confocal z sections stained with combinations of antibodies. Since our anti-23 
VP5 and anti-VP1-2 combination was not suitable we stained with either anti-VP5 24 
and pUL37 or anti-VP1-2 and pUL37 combinations.  The results showed the almost 25 
quantitative association of pUL37 with VP5+ve capsids and the same association for 26 
VP1-2 with pUL37+ve capsids (Figure 7b, panels II and III). These data indicate that 27 
VP1-2 remains on incoming capsids during infection with K.VP1-2ΔNLS and that the 28 
requirement for the NLS more likely reflects a direct involvement in capsid targeting.  29 
To pursue the defect in K.VP1-2ΔNLS capsid entry, we performed a similar 30 
analysis using electron microscopy of thin sections (70 nm) after high moi infection of 31 
the mutant and revertant.    For both the revertant and mutant, we readily observed 32 
internalised capsids, free of membranes in the cytosol of infected cells (Figure 8, 9).  33 
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However, consistent with the immunofluorescence analysis, a key qualitative 1 
difference was observed between the two, quantified in Figure 9c. The perimeter of 2 
nuclear envelope (NE) of 100 cells was scanned and scored for capsids in close 3 
proximity to the NE (within approximately 100 nm) and also classed as empty or 4 
DNA-containing capsids.  For the revertant virus we could detect such capsids, 5 
typical examples of which are shown in Figure 8 with approximately 85% of these 6 
being empty and the majority adjacent to pore structures (Figure 9c). In contrast, for 7 
K.VP1-2 ΔNLS, capsids in close proximity to the NE were rare and what few were 8 
observed retained DNA and were not associated with pores (Figure 9c).   Instead we 9 
observed capsids, frequently in close proximity to the centrioles within the 10 
microtubule organising centre, not wrapped in membranes and all containing DNA.  11 
Figure 9 a,b shows an example field with multiple full capsids (small arrowheads) in 12 
close proximity to the centriole (large single arrowhead). Taken together these data 13 
answer several questions. Firstly they show that ΔNLS virions, which exhibit a 14 
profound block in infection, were able to enter cells.  Moreover, although at the EM 15 
level it is difficult to be categorical, nevertheless we could not identify ΔNLS empty 16 
capsids in proximity to the nuclear pore.  Altogether, with the distinct phenotype and 17 
more quantitative analysis of capsid localisation by immunofluorescence and the 18 
clear failure to initiate gene expression, the most reasonable explanation for our data 19 
is that the ΔNLS mutant exhibits a major block in forward routing from the MTOC 20 
and/or docking with the nuclear pore, resulting in a profound block to the normal 21 
progression of infection.   These data provide evidence that the short NLS at position 22 
475 in VP1-2, which exhibits strong positional and sequence conservation in the 23 
homologues in all herpesviruses (2), is critical for virus spread and further that while 24 
dispensable for virion assembly per se, is key to normal entry early in infection via 25 
routing to the nuclear pore. 26 
        27 
DISCUSSION 28 
 Herpesvirus capsids must navigate the cytosolic environment of the cells 29 
which they infect, dock and engage with nuclear pores, and deposit their genomes 30 
across the pore for subsequent gene expression.  Any mechanistic understanding of 31 
these early pathways requires the identification and dissection of the virus and host 32 
proteins involved. However most of the potential virus candidates for an important 33 
 21
role in early entry are essential proteins required for virus assembly. Thus their 1 
complete deletion results in failure to assemble a particle and prevents any further 2 
detailed analysis of a specific role in entry and the mechanism involved.  VP1-2 is 3 
conserved in all herpesviruses and is absolutely essential for virus assembly (13, 15, 4 
34, 52).  However strong evidence for an additional  role of VP1-2 in entry was 5 
provided from previous data on the retention of a subset of tegument proteins 6 
including VP1-2 on infecting capsids (19, 23, 30, 37, 39, 40, 45, 51, 56, 61), on the 7 
failure of VP1-2-ve capsids to infect nuclei in polykaryocytes (52), and on a ts defect 8 
in entry mapping to VP1-2 (1, 5, 31).  Nevertheless any mechanistic understanding 9 
of the relevant pathways and the role of VP1-2 requires identification of variants 10 
wherein virion assembly and secondary infection still occur, yet virus propagation is 11 
defective. Here we construct and characterise a variant in which infection and virus 12 
assembly proceeds but virus propagation and cell to cell spread is profoundly 13 
blocked.  A summary of the features of this virus mutant is illustrated schematically in 14 
Figure 10. Taken together our data provide strong support for the proposal that the 15 
basic motif of VP1-2 functions as an NLS to promote successful transport to and/or 16 
interaction with nuclear pore complexes and that this is a critical requirement for 17 
successful infection.    18 
There could be several not mutually exclusive explanations to account for our 19 
observations since distinct events in transport, docking  or subsequent to nuclear 20 
pore engagement can all be involved in early nuclear entry (60). While VP1-2 has 21 
been shown to be required for intracellular microtubule-mediated capsid transport 22 
(38, 55, 61), our results indicate that a defect in the initial interaction and transport of 23 
the VP1-2ΔNLS mutant capsid, at least from the periphery of the cell, would not be 24 
the most likely explanation for the block in infection.  Although defects in early 25 
transport mechanisms, e.g., in peripheral interactions or in the kinetic efficiency of 26 
transport to the interior of the cell, are less likely explanations and not supported by 27 
current data, they will be addressed formally in future work when a fluorescent 28 
derivative of the VP1-2ΔNLS mutant can be constructed.  29 
It could have been that capsids were transported to the pore without a 30 
requirement for the VP1-2 NLS (but with a requirement for other specific 31 
capsid/tegument determinants), with the NLS being involved in promoting tight 32 
engagement with the pore or a key event subsequent to pore interaction per se. For 33 
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example, in adenovirus, capsid binding to nuclear pores has been reported to be 1 
independent of importin and presumably of any NLS motifs in capsid proteins, and 2 
mediated instead by direct capsid binding to pore components including Nup214 3 
(58).  However our data support a role for VP1-2 NLS interactions specifically in 4 
routing to the pore, though there could be several not mutually exclusive 5 
explanations regarding the detailed processes involved.  For example while not 6 
required for peripheral transport, it could be that the NLS is required for promoting 7 
subsequent transport of capsids directly, i.e. with the NLS determinant directly 8 
interacting with the cytoskeleton associated transport machinery, or indirectly by 9 
binding some type of NLS receptor, e.g., an importin and by virtue of this interaction, 10 
promoting transport to the pore. It could also be that the NLS is involved in capsid 11 
detachment from microtubules after retrograde transport and indeed it is possible 12 
that these events are coupled (see below).    13 
It has previously been reported that HSV virions stripped of their envelope by 14 
detergent extraction, could bind to nuclear pores in vitro (46).  Such in vitro binding 15 
could be inhibited to some degree either by a general broad antibody to multiple 16 
nucleoporins or by antibody to importin β and importin β was reported to be sufficient 17 
to promote capsid binding to isolated nuclei (46).  No specific virus receptors were 18 
identified for such binding, but mild trypsin treatment of the capsids, removing 19 
several tegument proteins including VP13/14, VP22, VP16, and VP1-2 was reported 20 
to inhibit capsid-nuclear interaction. Also antibody to VP1-2 itself, when scrape 21 
loaded into cells resulted in a reduction in capsid accumulation at the nuclear pore 22 
(11).  It is tempting to speculate that the pronounced requirement for the NLS of 23 
VP1-2 we now demonstrate could reflect an involvement of importin β.  However it 24 
was also reported that importin α, which directly interacts with NLS motifs (17, 18) 25 
did not support capsid binding, and that an NLS-peptide conjugate could not 26 
compete for capsid-pore docking.  This would imply that the VP1-2 NLS did not bind 27 
importin α but rather had specificity for importin β.  Moreover, antibody to 28 
nucleoporins (46) also inhibited capsid binding in vitro and siRNA knockdown of 29 
nucleoporins reduced capsid accumulation at the nucleus in vivo (11). These effects 30 
though modest indicate that other interactions may be involved in capsid-pore 31 
interactions (see below).  32 
 23
 The distinct congregation of the ΔNLS mutant capsids around the MTOC and 1 
our failure to detect any empty capsids around the pore indicate that the NLS 2 
somehow promotes the forward routing of capsids from the MTOC and/or the 3 
detachment from the MTOC or surrounding region. The most straightforward 4 
explanation is that, without any necessary spatial restriction, the VP1-2NLS interacts 5 
with a cellular component as it undergoes retrograde transport to the interior of the 6 
cell retaining the component on the virus capsid.  Some downstream event,  possibly 7 
but not necessarily involving the NLS, then promotes release or alteration of the 8 
capsid and transport towards the pore dependent upon VP1-2 and its NLS 9 
associated component(s).  This explanation would not rule out additional 10 
downstream roles for the NLS once docked at the pore.  The congregation of the 11 
ΔNLS mutant around the MTOC would then be a result of the inefficient directed 12 
transport towards the pore and/or an actual retention of the ΔNLS capsids within and 13 
around the MTOC region.   14 
It is also possible that the NLS functions or interacts with its potential receptor 15 
in a spatially restricted way once at the MTOC, a region known to have particular 16 
structure and a matrix like organisation (12, 26, 33).  One explanation for this could a 17 
regulated conformational exposure such as is thought to occur on the capsid of 18 
hepatitis B virus (HBV).  HBV capsids (from bacterially expressed core protein), bind 19 
nuclear pores at least in permeabilized cells dependent upon phosphorylation at 20 
residues adjacent to an NLS motif. It is proposed that phosphorylation exposes the 21 
NLS for importin binding and pore docking (27).  It could be that the disposition or 22 
activity of the VP1-2 NLS is regulated, either to promote exposure and function in 23 
entry, or to mask or inhibit its activity later after de novo synthesis and incorporation 24 
into newly assembled capsids during exit.  An example of an event which might 25 
promote function or presentation of the NLS would be in proteolytic cleavage of VP1-26 
2 which one report has indicated may be relevant at some stage of early infection 27 
(25).  28 
Furthermore it is intriguing that in certain circumstances e.g., for intra-axonal 29 
transport, certain importin species have been shown to be complexed with the 30 
retrograde motor dynein. Signalling pathways induce the rapid translation of spatially 31 
restricted importin β mRNA into protein that is distant from the cell body and then 32 
complexes with importin α and dynein to enable nuclear translocation of cargo (22, 33 
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48). By this manner it is possible that an NLS acts as a determinant both for 1 
microtubule-associated transport, and nuclear pore interaction.  While such a 2 
mechanism is possible, it is more plausible for the neurotropic herpesviruses. Other 3 
mechanisms not requiring spatially restricted NLS interactions are more likely to 4 
explain the requirement for the VP1-2 NLS in core replication pathways in culture. 5 
Thus the NLS motif could be engaged at any of a number of points, but be critically 6 
important in forward transport from the MTOC area.     7 
Clearly other determinants in VP1-2 are also critical for virus replication.   8 
Insertional and deletion mutations in several regions abrogate VP1-2 function.  Little 9 
is known about the basis of the VP1-2 disruption, though it is likely that such mutants 10 
will affect the known essential roles of VP1-2 in recruiting additional tegument 11 
proteins in the assembly pathway.  Indeed certain mutants have been shown to 12 
specifically disrupt VP1-2 interactions with other tegument proteins required for 13 
assembly (7, 15, 29, 32, 34, 41, 42).  One specific VP1-2 determinant,  the extreme 14 
carboxy terminal region, promotes with the essential capsid protein pUL25 (8, 34).  15 
In pseudorabies virus, deletion of the extreme C-terminal 23 residues abrogates 16 
virus replication (34, 42), an effect which has been  attributed to disruption of VP1-2 17 
recruitment to capsid possibly by direct interaction with pUL25 (10, 47). Since pUL25 18 
itself has also been implicated in early events during the initiation of infection (47, 49) 19 
clearly such additional VP1-2 determinants could play a role in entry events. Indeed 20 
it has previously been shown that pUL25 when expressed individually could bind 21 
nucleoporins, and thus it has been proposed that it could act on capsids as an 22 
interface with the nuclear pore (47).  If this were the case, from our results it would 23 
be insufficient to promote nuclear pore engagement in the absence of the VP1-2 24 
NLS. Nevertheless it remains possible that VP1-2 plays a role in promoting pUL25 25 
function after docking.  It could for example be that downstream of NLS-promoted 26 
routing to the pore, the NLS itself or additional determinants in VP1-2 and/or pUL25 27 
engage with specific pore components such as Nup214 or Nup358.   However the 28 
role of C-terminus of VP1-2 may be more complicated than first anticipated since 29 
recent results indicate that the C-terminal is not required for VP1-2 function in virion 30 
assembly, but rather is specifically required to retain the protein on capsids as it 31 
infects secondary cells (53).  This apparently indicates that VP1-2 remains bound to 32 
newly formed capsids and promotes virion assembly without requiring the C-terminal 33 
pUL25–interacting region, but detaches from capsids after they infect cells if this C-34 
 25
terminal region is not present. This determinant appears to act in a distinct fashion 1 
from the NLS identified here. 2 
In conclusion our results advance understanding of the role of VP1-2 3 
specifically in entry pathways of HSV.  The characterisation of the phenotype and the 4 
nature of block to entry uncouple critical determinants in VP1-2 for early intracellular 5 
routing pathways. These results provide a framework for future detailed analysis of 6 
the host cell factors involved, since these can be linked to a physiologically relevant 7 
and critical determinant whose alteration has a profound phenotype.  Furthermore, 8 
considering the conserved and essential nature of VP1-2 and presence of the basic 9 
NLS-like motif in a similar position in all homologues (2),  we believe that this motif 10 
may play a similar critical role in other herpesvirus species. Finally, in principle 11 
targeting the function of the NLS could provide a useful therapeutic avenue and the 12 
debilitated virus itself could prove useful in other settings such as gene therapy 13 
where entry is required but second round spread not desirable, or in vaccine 14 
applications.    15 
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FIGURE LEGENDS 1 
 2 
Figure 1. Deletion of the VP1-2 abolishes plaque formation.  3 
(a) Schematic summary of VP1-2, indicating the N-terminal USP domain,  the 4 
highly basic NLS motif contained within a poorly conserved region, the large 5 
central region (grey) and a C-terminal conserved region (blue). Regions 6 
relevant to interactions with VP16, pUL37 and pUL25 are also indicated (10, 7 
15, 30, 34, 41, 47, 59). (b) Serial dilutions of K.VP1-2ΔNLS were examined for 8 
plaque formation in complementing HS30 cells versus normal Vero cells.  (c) 9 
Quantitative analysis of plaquing efficiency of the mutant versus KOS w/t in 10 
Vero and HS30 cells.  Plaque formation is diminished by at least 7 logs and is 11 
essentially undetected in Vero cells compared to HS30 cells. (d) Comparison 12 
of the w/t and mutant strains in multi-step growth curve after low moi infection 13 
(0.01 pfu /cell, based on titres in complementing cells) in Vero (solid symbols) 14 
or HS30 (open symbols). Yields were titrated in HS30 cells. (e) Comparison of 15 
the w/t and mutant strain replication in single-step growth curves after high 16 
moi infection in Vero or HS30  (5 pfu /cell, based on titres in complementing 17 
cells).  18 
 19 
Figure 2. Initial infection of single cells by K.VP1-2ΔNLS and failure to 20 
spread.   21 
(a) Vero cells were infected with K.VP1-2ΔNLS or KOS w/t at a moi calculated 22 
to infect 1/500 cells. Monolayers were examined after three days for virus 23 
proteins by immunofluorescence. (ICP4, green; pUL37, red; nuclear 24 
counterstain blue).  For the w/t virus, plaques had obviously grown and 25 
contained numerous antigen positive cells. In contrast for the mutant, single 26 
antigen positive cells were observed, (both antigens were detected though the 27 
red channel obscures the green in this merged example) but infection was 28 
never detected and did not progress in surrounding cells.   (b) To examine the 29 
induction of expression of the w/t VP1-2 during propagation in complementing 30 
cells,  RSC-HAUL36 cells were infected with K.VP1-2ΔNLS at a moi of 5 31 
(based in titres in HS30 cells), samples harvested at the times indicated and 32 
examined for expression of the endogenous w/t VP1-2, by virtue of the HA-33 
 31
tag, total VP1-2 using anti-VP1-2 or the major capsid protein VP5.   1 
Extracellular virus (see also Figure 5), from K.VP1-2ΔNLS and K.VP1-2 
2ΔNLS.R amplified in the complementing RSC-HAUL36 cells, and purified by 3 
Ficoll gradient centrifugation were analysed to assess the incorporation of the 4 
endogenous VP1-2 into the virion particles produced in these cells in relation 5 
to VP5 (lanes 10,11).   6 
 7 
Figure 3. Comparison of protein expression during infection by K.VP1-8 
2ΔNLS and its revertant.   9 
(a) RSC or RSC-HAUL36 cells were infected in parallel with the mutant  10 
K.VP1-2ΔNLS, the revertant K.VP1-2ΔNLS.R or KOS w/t virus at a moi of 5. 11 
Samples were harvested at the times indicated and expression of a series of 12 
delayed early or late proteins, VP5, pUL37, UL25, gD and VP1-2 itself was 13 
examined by Western blotting using fluorescent antibodies and quantitative 14 
detection as described in materials and methods.  (b) As above, examining 15 
immediate-early (ICP4) or delayed early (ICP8) every h for 12 h.  Some 16 
reduction was observed in the abundance of ICP4 (long arrow) though little 17 
significant difference for ICP8. (A non -specific band migrating just below ICP4 18 
was occasionally observed,  indicated by the short arrow). The parental KOS 19 
strain exhibited slightly increased expression of both proteins, estimated as 2-20 
4 fold by quantitative analysis over the ΔNLS and ΔNLS.R viruses. 21 
 22 
Figure 4. Comparison of protein localisation during infection by K.VP1-23 
2ΔNLS and KOS w/t.   24 
(a) Vero cells were infected with KOS or the mutant  K.VP1-2ΔNLS virus at a 25 
moi of 5. Cultures were fixed after 16 h and processed for 26 
immunofluorescence as described.  Patterns of localisation as discussed in 27 
the text were similar for both the w/t and mutant viruses.  (b) RSC or Vero 28 
cells were infected and processed as in panel a and stained for VP1-2 29 
localisation. 30 
 31 
 32 
 32
Figure 5.  Ultrastructural analysis of capsid and virion formation in 1 
K.VP1-2ΔNLS infected cells.   2 
RSC cells were infected in parallel with KOS or the mutant  K.VP1-2ΔNLS at a 3 
moi of 5,  fixed at 16 h post infection and processed for thin section electron 4 
microscopy as described in materials and methods. Sections for K.VP1-5 
2ΔNLS are shown in panels a-c and for KOS in panel d-f. Capsid formation 6 
was readily apparent for both mutant and w/t viruses (panels a,d; small white 7 
arrows indicate nucleocapsids; large white arrowhead a particle in primary 8 
envelopment).   Cytoplasmic envelopment was also observed for mutant and 9 
w/t viruses (panels b,e; black arrows indicate wrapping during secondary 10 
envelopment).  Finally the presence of assembled virions are shown in 11 
example panels c and f for the mutant and revertant respectively.  Panels g, 12 
and h show further examples of assembled extracellular virions readily 13 
observed for the mutant virus.  Generally little difference in the main 14 
ultrastructural features of infection were observed for the w/t versus the 15 
mutant strains and all qualitative features of capsid and virion assembly could 16 
be observed. Similar results were obtained with K.VP1-2ΔNLS revertant virus 17 
and in different cell lines (Vero and HaCaT cells). Scale bars are 500 nm. 18 
 19 
Figure 6.  Characterisation of K.VP1-2ΔNLSNC extracellular virus 20 
produced from non-complementing cells.    21 
HaCaT cells were infected with K.VP1-2ΔNLSC or the revertant virus at a moi 22 
of 5 (estimated from titration in complementing cells). We used HaCaT cells 23 
which we find helps increase overall yields of all herpesviruses strains.  Media 24 
was harvested 16 h after infection, clarified and extracellular virus pelleted by 25 
centrifugation at 19k rpm for 90 min. Samples of pelleted virus showed slightly 26 
increased amounts of virion proteins for the mutant.  Samples were adjusted 27 
(based on major capsid protein VP5) and analysed by SDS-PAGE. (a) Mutant 28 
and revertant virus exhibited similar qualitative and quantitative profiles of 29 
structural proteins including VP1-2, VP5.  (b) Equalised samples were 30 
analysed by western blotting for the presence of a number of structural 31 
components as indicated.  (c) Samples of extracellular particles from revertant 32 
or mutant infected cell medium, analysed by negative staining.  Various 33 
 33
degrees of stain penetration were observed for both mutant and revertant and 1 
examples illustrating partially stained intact particles are shown for both. Scale 2 
bars are 200 nm. (d) Comparison of specific infectivity of K.VP1-2ΔNLSNC and 3 
revertant extracellular virus particles, equalised on the basis of major capsid 4 
protein and titred for plaque formation in complementing HS30 cells.  On a 5 
capsid standardised basis, K.VP1-2ΔNLSNC particles exhibited approximately 6 
600-fold lower infectivity. (e) Comparison of infectivity at the single cell level. 7 
Vero or HS30 cells were infected with serial dilutions of the revertant virus 8 
designed to give low moi infections within a range of 1:100 to 1:3 cells 9 
infected.  Cells were infected in parallel with K.VP1-2ΔNLSNC particles with an 10 
equivalent range based on equalised capsid protein. Cells were fixed 6 h after 11 
infection, stained with antibody to detect ICP4 and counterstained with DAPI 12 
to enumerate cells. Numerous cells were counted for each virus at each 13 
dilution.  Typical fields shown are Vero cells with the highest amount of input 14 
virus to emphasis the difference in infectivity between the revertant and 15 
mutant, quantified in panel f. (g) Based on the titre of the revertant virus, cells 16 
were infected at high moi (5 pfu/cell) with the revertant virus or an equivalent 17 
input of mutant virus, based on standardisation of capsid protein in 18 
extracellular virus particles. Cells were harvested for Western blotting at the 19 
times indicated analysing in this case for a typical delayed-early protein ICP8, 20 
or the late major capsid protein VP5.   21 
 22 
Figure 7. Immunofluorescence analysis of K.VP1-2ΔNLSNC virus entry.  23 
Cells (RSC) were infected with extracellular virus of either the revertant 24 
ΔNLS.R or mutant virus ΔNLS produced from non-complementing cells. 25 
Infection was at a moi of 100 for the revertant or an equivalent amount of the 26 
mutant based on standardisation of VP5 in the extracellular purified virus. To 27 
help synchronise infection, cells were washed with cold media and incubated 28 
at 4°C after adding the inoculum.  After 1 h, warmed media was added and 29 
the cells were further incubated for 2 or 4 h at 37°C prior to fixation and 30 
permeabilisation. Control samples maintained at 4°C were also examined as 31 
controls. Samples were stained for the major capsid protein VP5 and 32 
counterstained with DAPI to detect nuclei.  The panels show typical examples 33 
 34
of many fields examined (using a x40 objective to capture multiple cells in 1 
each field), and present both channels for each virus at the indicated time.  2 
The VP5 channel only is shown in panels IV and VIII, highlighting the contrast 3 
between the revertant and mutant virus. Scale bars are 50 µm (b) High 4 
resolution confocal section of cells infected with the ΔNLS virus stained with 5 
anti-VP5 (green),  anti-PCM1 (red) and DAPI (panel I; scale bar, 10 µm). The 6 
inset (scale bar, 2 µm) shows the pericentriolar PCM1 accumulations with 7 
congregating capsids in the same location, though the capsids do not 8 
necessarily directly overlap with the PCM1-specific material. Higher 9 
magnification images of capsids (VP5) and tegument proteins (pUL37 and 10 
VP1-2) colocalizing at the MTOC perinuclear accumulations of ΔNLS virus 11 
infection (panels II and III; scale bars are 5 µm) (c) Graph showing the 12 
quantification of the MTOC accumulation for revertant and mutant capsids.  13 
Defined and unbiased areas of interest were applied around the PCM1 14 
pericentriolar region, and the accumulated density of pixels in the green 15 
channel for VP5 in the same areas calculated.  Each vertical bar represents 16 
an individual cell. Approximately 130 cells were evaluated for each virus.  17 
 18 
Figure 8.  EM analysis showing nuclear pore interaction during entry of 19 
the ΔNLS revertant virus. 20 
Vero cells were infected with the revertant virus K.VP1-2ΔNLS.R at an moi of 21 
500 PFU/cell. The cells were washed with cold media and incubated at 4°C 22 
after adding the inoculum. After 1 h, warmed media was added and the cells 23 
incubated for 4 h at 37°C, then fixed and processed for thin section (70 nm) 24 
ultrastructural analysis as described in materials and methods. N and C 25 
indicate nucleus and cytoplasm respectively.  An example section is shown 26 
with its inset illustrating the presence of empty capsids in close proximity to 27 
the nuclear pore.  Additional insets are shown from additional independent 28 
sections illustrating the same feature of nuclear pore proximity and empty 29 
capsids.  Scale bars are 500 nm in the main image and 250 nm for the insets. 30 
As is the case in thin section analysis, capsids immediately adjacent to the NE 31 
are only a subset of infecting capsids but were readily observed for the w/t 32 
 35
virus. Total numbers of capsids within 100 nm of the NE are quantitated in 1 
Figure 9c. 2 
 3 
Figure 9.  EM analysis of the block in K.VP1-2ΔNLSNC virus entry. 4 
In parallel with the analysis shown in Figure 8, cells were infected with the 5 
mutant virus K.VP1-2ΔNLSNC, fixed and processed.  N and C indicate nucleus 6 
and cytoplasm respectively. We readily detected cytoplasmic capsids,  7 
frequently in close proximity to the centrioles of the MTOC but capsids close 8 
to the NE were rare. (a) Representative field indicating the position within the 9 
cell and larger magnification in inset (b), showing full capsids of the infecting 10 
mutant. The single large arrowhead indicates the position of one of the 11 
centrioles with small arrows pointing to 6 capsids accumulated around the 12 
MTOC area. (c) Quantification of full and empty capsids from K.VP1-2ΔNLS 13 
and revertant infected cells. The total perimeter of the NE in 100 cells was 14 
scanned for capsids in close proximity (within 100 nm distance from the NE) 15 
and scored as empty or DNA-containing capsids.  We found only rare 16 
examples of capsids close to the NE, these were not adjacent to pores and 17 
were DNA containing.  Scale bars are 500nm.  18 
 19 
Figure 10.  Summary of propagation of K.VP1-2ΔNLS in complementing 20 
and normal cell types.   21 
Three rows (a,b,c) summarise the outcomes of K.VP1-2ΔNLS infection. (a) 22 
Complementing cells (shaded in green) contain the w/t UL36 gene,  which is 23 
induced after infection with K.VP1-2ΔNLS mutant (Figure 2b).  The w/t VP1-2 24 
is recruited onto virions (green virions with green dots indicating functional 25 
VP1-2 (Figure 2b).    Note that a population of mutant VP1-2, indicated in 26 
orange could be recruited onto particles,  and virions may have mixed 27 
populations and different distributions (a, II?).  It may be that not all the VP1-2 28 
incorporated needs to be w/t, though neither the distribution of w/t versus 29 
mutant VP1-2 nor the amount of w/t VP1-2 required for successful infection is 30 
known.  The mutant can replicate, spread and form plaques in complementing 31 
cells. (b) Upon infection of non-complementing cells (shaded in grey) with the 32 
complemented virus, the virus can infect, undergo gene expression and 33 
 36
produce extracellular virus (orange virions) which now contains mutant VP1-1 
2ΔNLS (orange dots, II).  Our results indicate that this virus contains VP1-2 
2ΔNLS and appears structurally similar to w/t virus with a similar cohort of 3 
proteins,  can infect cells,  but is blocked at the MTOC prior to successful 4 
nuclear engagement.  (c) Producing K.VP1-2ΔNLS virus in non-5 
complementing cells results in the formation of extracellular non-6 
complemented virions. These virions have a profound block in infection at 7 
MTOC prior to nuclear engagement.  8 
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